RTTNews | May 12, 2021 04:27PM EDT

16:27 Wednesday, May 12, 2021 (RTTNews.com) - Qiagen N.V. (QGEN) Wednesday said that FDA has given Emergency Use Authorization to its Covid-19 test QIAreach Anti-SARS-CoV-2 Total Test.

The approval allows Qiagen to start making its portable antibody testing device available to health-care professionals in the U.S. According to the company, the antibody test takes only about 10 minutes to identify whether a person carries antibodies to the SARS-CoV-2 virus as a result of prior infection.

The QIAreach Anti-SARS-CoV-2 Total Test is a serological test that has been shown to have a sensitivity of 93.85% and a specificity of 97.83%.

Read the original article on RTTNews ( https://www.rttnews.com/3194344/qiagen-s-covid-19-antibody-test-gets-emergency-use-authorization-from-fda.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2021 RTTNews.com All Rights Reserved